Zum Inhalt springen
Neurogyn
  • Start
  • Neuigkeiten
  • Erkrankungen
    • Blase
    • Darm
    • Gangstörung
  • Therapien
    • The GNS-therapy ®
    • LION Prozedur®
  • Professional Training
  • Produkte
  • Über uns
  • Website-Suche umschalten
Menü Schließen
  • Start
  • Neuigkeiten
  • Erkrankungen
    • Blase
    • Darm
    • Gangstörung
  • Therapien
    • The GNS-therapy ®
    • LION Prozedur®
  • Professional Training
  • Produkte
  • Über uns
  • Website-Suche umschalten
Mehr über den Artikel erfahren Neuropelveology, the story of 30 years of Pioneering

Neuropelveology, the story of 30 years of Pioneering

Neuropelveology – The Story of 30 Years of Pioneering The field of neuropelveology was pioneered by Professor Marc Possover, a gynecological surgeon based in Switzerland. In the early 2000s. He…

WeiterlesenNeuropelveology, the story of 30 years of Pioneering
Mehr über den Artikel erfahren Hypersensitivity of the bladder

Hypersensitivity of the bladder

HYPERSENSITIVITY OF THE BLADDER The hypersensitivity of the bladder should not be confused with OAB (Overactive Bladder) Summary Bladder hypersensitivity is a complex and often underdiagnosed condition that significantly impacts…

WeiterlesenHypersensitivity of the bladder

NeuroGyn Revolutionizes Pelvic Neuromodulation with Groundbreaking Clinical Study – June 2023

Link here In a groundbreaking clinical study, published as peer-review in the Journal of Minimally Invasive Gynecology in 2023 – the official Journal of the American Association of Gynecological Laparoscopists…

WeiterlesenNeuroGyn Revolutionizes Pelvic Neuromodulation with Groundbreaking Clinical Study – June 2023

Neurogyn Secures Groundbreaking Patents in Pelvic Neuromodulation – October 2022 

Neurogyn Secures Groundbreaking Patents in Pelvic Neuromodulation In a significant stride towards revolutionizing the field of pelvic neuromodulation, Neurogyn AG, the leading medical technology company in the field of neuropelveology,…

WeiterlesenNeurogyn Secures Groundbreaking Patents in Pelvic Neuromodulation – October 2022 

Imec And NeuroGyn AG Collaborate On Advanced Neurostimulation Device For Pelvic Nerve Disorders

Imec 01.10.22  Link: click here Imec is developing a next-generation implantable device for peripheral nerve stimulation together with NeuroGyn AG, a Swiss medtech  company specialized in neurostimulaton and surgical solutions for pelvic…

WeiterlesenImec And NeuroGyn AG Collaborate On Advanced Neurostimulation Device For Pelvic Nerve Disorders

Die „Pudendal LION Prozedure“ zur Behandlung der Reizblase

Die "Pudendal LION Prozedure" zur Behandlung der Reizblase Die "Pudendal LION Prozedure" zur Behandlung der Reizblase findet Anerkennung in der USA und wird in "The Journal of Minimal Invasive Gynecology"…

WeiterlesenDie „Pudendal LION Prozedure“ zur Behandlung der Reizblase

NeuroGyn AG – Gewinner des „Swiss Technology Award 2014 – Kategorie „Inventors“

NeuroGyn AG – Gewinner des „Swiss Technology Award 2014 – Kategorie „Inventors“ Die Ansätze in der Becken-Neuromodulation reichen von der Behandlung von Schmerzen und Blasen-/Darmentleerungsstörungen (Inkontinenz, Reizblase) bis zur Wiederherstellung…

WeiterlesenNeuroGyn AG – Gewinner des „Swiss Technology Award 2014 – Kategorie „Inventors“
  • Gehe zur vorherigen Seite
  • 1
  • 2
  • 3

Neuigkeiten

  • PosStim™: Advancing Toward Direct Pelvic Neuromodulation
  • From Peripheral to Pelvic Neuromodulation
  • Building the Future of Targeted Pelvic Neuromodulation – Bioelectronic Medicine
  • From Surgical Innovation to Bioelectronic Medicine
  • NEUROGYN – THE PATENTED NEUROMODULATION ECOSYSTEM

Contact

Neurogyn Logo line white

Ringstrasse 17
CH – 6332 Hagendorn
m.possover@neurogyn.com

Neue Beiträge

  • PosStim™: Advancing Toward Direct Pelvic Neuromodulation
  • From Peripheral to Pelvic Neuromodulation
  • Building the Future of Targeted Pelvic Neuromodulation – Bioelectronic Medicine
  • From Surgical Innovation to Bioelectronic Medicine
  • NEUROGYN – THE PATENTED NEUROMODULATION ECOSYSTEM
Copyright 2019 NeuroGyn AG all rights reserved – Foss & Haas
DE
EN DE